Skip to text.To Contents

National Drug Intelligence Center
National Methamphetamine Threat Assessment 2007
November 2006


D-Links

Figure 1. Reported methamphetamine laboratory seizures, 2001-2006.

Bar graph showing the number of reported methamphetamine laboratory seizures for the years 2001-2006.

There were 8,460 reported methamphetamine laboratory seizures in 2001.
There were 9,267 reported methamphetamine laboratory seizures in 2002.
There were 10,212 reported methamphetamine laboratory seizures in 2003.
There were 10,015 reported methamphetamine laboratory seizures in 2004.
There were 5,846 reported methamphetamine laboratory seizures in 2005.
There were 2,159 reported methamphetamine laboratory seizures in 2006*.

Source: National Clandestine Laboratory Seizure System (Run date--September 13, 2006).
*Data for 2006 are incomplete.

Return to Figure 1.


Figure 2. Reported methamphetamine superlab seizures, 2001-2006.

Bar graph showing the number of reported methamphetamine superlab seizures for the years 2001-2006.

There were 244 reported methamphetamine superlab seizures in 2001.
There were 143 reported methamphetamine superlab seizures in 2002.
There were 130 reported methamphetamine superlab seizures in 2003.
There were 55 reported methamphetamine superlab seizures in 2004.
There were 35 reported methamphetamine superlab seizures in 2005.
There were 17 reported methamphetamine superlab seizures in 2006*.

Source: National Clandestine Laboratory Seizure System (Run date--September 13, 2006).
*Data for 2006 are incomplete.

Return to Figure 2.


Figure 3. Primary methamphetamine admissions, 2000-2004.

Graph showing an increasing trend in the number of primary methamphetamine admissions for the years 2000-2004.

There were 67,568 admissions in 2000; 82,113 admissions in 2001; 105,981 admissions in 2002; 117,259 admissions in 2003; and 129,079 admissions in 2004.

Source: Treatment Episode Data Set.

Return to Figure 3.


Figure 4. Estimated number of methamphetamine users dependent on or abusing illicit drugs or stimulants, 2002-2004.

Bar graph showing the estimated number of methamphetamine users dependent on or abusing illicit drugs or stimulants for the years 2002-2004, broken down by type of dependence or abuse.

In 2002, an estimated 63,000 users were dependent on or abusing stimulants, an estimated 101,000 users were dependent on or abusing other illicit drugs, and an estimated 433,000 had no dependence or abuse.

In 2003, an estimated 92,000 users were dependent on or abusing stimulants, an estimated 158,000 users were dependent on or abusing other illicit drugs, and an estimated 357,000 had no dependence or abuse.

In 2003, an estimated 130,000 users were dependent on or abusing stimulants, an estimated 216,000 users were dependent on or abusing other illicit drugs, and an estimated 237,000 had no dependence or abuse.

Source: National Survey on Drug Use and Health.

Return to Figure 4.


Figure 5. Percentage of primary methamphetamine or amphetamine admissions, by route of administration, 1993-2004.

Graph showing the percentage of primary methamphetamine or amphetamine admissions for the years 1993-2004, by route of administration.

In 1993, the route of administration for 15.0 percent of admissions was smoking, 42.7 percent was inhalation, 29.0 percent was injection, and 12.6 percent was oral.
In 1994, the route of administration for 17.1 percent of admissions was smoking, 43.3 percent was inhalation, 29.0 percent was injection, and 10.0 percent was oral.
In 1995, the route of administration for 18.9 percent of admissions was smoking, 43.0 percent was inhalation, 28.7 percent was injection, and 8.8 percent was oral.
In 1996, the route of administration for 22.1 percent of admissions was smoking, 39.0 percent was inhalation, 29.7 percent was injection, and 8.5 percent was oral.
In 1997, the route of administration for 27.4 percent of admissions was smoking, 36.3 percent was inhalation, 28.4 percent was injection, and 7.3 percent was oral.
In 1998, the route of administration for 32.0 percent of admissions was smoking, 31.0 percent was inhalation, 29.1 percent was injection, and 7.1 percent was oral.
In 1999, the route of administration for 35.1 percent of admissions was smoking, 25.2 percent was inhalation, 29.2 percent was injection, and 9.8 percent was oral.
In 2000, the route of administration for 39.8 percent of admissions was smoking, 21.0 percent was inhalation, 28.1 percent was injection, and 10.3 percent was oral.
In 2001, the route of administration for 45.1 percent of admissions was smoking, 18.6 percent was inhalation, 26.4 percent was injection, and 8.7 percent was oral.
In 2002, the route of administration for 50.7 percent of admissions was smoking, 17.1 percent was inhalation, 23.3 percent was injection, and 7.4 percent was oral.
In 2003, the route of administration for 56.2 percent of admissions was smoking, 15.1 percent was inhalation, 21.6 percent was injection, and 5.7 percent was oral.
In 2004, the route of administration for 59.1 percent of admissions was smoking, 13.6 percent was inhalation, 21.1 percent was injection, and 4.9 percent was oral.

Source: Treatment Episode Data Set.

Return to Figure 5.


Figure 6. Nine OCDETF regions.

U.S. map showing the nine OCDETF regions.

The Pacific region consists of Alaska, American Samoa, Hawaii, Guam, the Northern Mariana Islands, northern and central California, Idaho, Nevada, Oregon, and Washington.

The West Central region consists of Arkansas, Colorado, the southern portion of Illinois, Iowa, Kansas, Missouri, Montana, Nebraska, North Dakota, South Dakota, Utah, and Wyoming.

The Southwest region consists of southern California, Arizona, New Mexico, Oklahoma, and Texas

The Southeast region consists of Louisiana, Mississippi, Alabama, Georgia, North Carolina, South Carolina, and Tennessee.

The Florida/Caribbean region consists of Florida, Puerto Rico, and the U.S. Virgin Islands.

The Great Lakes region consists of Indiana, the northern portion of Illinois, Kentucky, Michigan, Minnesota, Ohio, and Wisconsin.

The Mid-Atlantic region consists of Delaware, Maryland, Pennsylvania, Virginia, and West Virginia.

The New York/New Jersey region consists of New Jersey and New York.

The New England region consists of Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont.

Return to Figure 6.


Map 1. National Drug Threat Survey 2006 greatest drug threat as reported by state and local agencies.

U.S. map with bar graph showing greatest drug threat as reported by state and local agencies superimposed.

36.5 percent of state and local agencies reported cocaine as the greatest drug threat.
8.5 percent of state and local agencies reported heroin as the greatest drug threat.
38.8 percent of state and local agencies reported methamphetamine as the greatest drug threat.
11 percent of state and local agencies reported marijuana as the greatest drug threat.
3.9 percent of state and local agencies reported pharmaceuticals as the greatest drug threat.

Return to Map 1.


Map 2. National Drug Threat Survey 2006 greatest drug threat by OCDETF region.

U.S. map with bar graphs showing greatest drug threats by region superimposed.

Pacific Region
2.7 percent of state and local agencies reported cocaine as the greatest drug threat.
0.0 percent of state and local agencies reported heroin as the greatest drug threat.
92.2 percent of state and local agencies reported methamphetamine as the greatest drug threat.
4.1 percent of state and local agencies reported marijuana as the greatest drug threat.
0.6 percent of state and local agencies reported pharmaceuticals as the greatest drug threat.

Southwest Region
16.2 percent of state and local agencies reported cocaine as the greatest drug threat.
1.3 percent of state and local agencies reported heroin as the greatest drug threat.
74.6 percent of state and local agencies reported methamphetamine as the greatest drug threat.
6.3 percent of state and local agencies reported marijuana as the greatest drug threat.
0.6 percent of state and local agencies reported pharmaceuticals as the greatest drug threat.

West Central Region
17.6 percent of state and local agencies reported cocaine as the greatest drug threat.
1.4 percent of state and local agencies reported heroin as the greatest drug threat.
76.8 percent of state and local agencies reported methamphetamine as the greatest drug threat.
3.5 percent of state and local agencies reported marijuana as the greatest drug threat.
0.3 percent of state and local agencies reported pharmaceuticals as the greatest drug threat.

Great Lakes Region
39.4 percent of state and local agencies reported cocaine as the greatest drug threat.
8.6 percent of state and local agencies reported heroin as the greatest drug threat.
27.6 percent of state and local agencies reported methamphetamine as the greatest drug threat.
17.1 percent of state and local agencies reported marijuana as the greatest drug threat.
6.5 percent of state and local agencies reported pharmaceuticals as the greatest drug threat.

Southeast Region
54.7 percent of state and local agencies reported cocaine as the greatest drug threat.
0.9 percent of state and local agencies reported heroin as the greatest drug threat.
36.3 percent of state and local agencies reported methamphetamine as the greatest drug threat.
3.0 percent of state and local agencies reported marijuana as the greatest drug threat.
4.3 percent of state and local agencies reported pharmaceuticals as the greatest drug threat.

Florida/Caribbean Region
75.6 percent of state and local agencies reported cocaine as the greatest drug threat.
0.0 percent of state and local agencies reported heroin as the greatest drug threat.
12.7 percent of state and local agencies reported methamphetamine as the greatest drug threat.
9.5 percent of state and local agencies reported marijuana as the greatest drug threat.
0.4 percent of state and local agencies reported pharmaceuticals as the greatest drug threat.

Mid-Atlantic Region
54.7 percent of state and local agencies reported cocaine as the greatest drug threat.
19.9 percent of state and local agencies reported heroin as the greatest drug threat.
3.9 percent of state and local agencies reported methamphetamine as the greatest drug threat.
15.0 percent of state and local agencies reported marijuana as the greatest drug threat.
4.2 percent of state and local agencies reported pharmaceuticals as the greatest drug threat.

New York/New Jersey Region
47.0 percent of state and local agencies reported cocaine as the greatest drug threat.
18.5 percent of state and local agencies reported heroin as the greatest drug threat.
1.6 percent of state and local agencies reported methamphetamine as the greatest drug threat.
25.9 percent of state and local agencies reported marijuana as the greatest drug threat.
4.9 percent of state and local agencies reported pharmaceuticals as the greatest drug threat.

New England Region
33.2 percent of state and local agencies reported cocaine as the greatest drug threat.
37.6 percent of state and local agencies reported heroin as the greatest drug threat.
1.9 percent of state and local agencies reported methamphetamine as the greatest drug threat.
15.5 percent of state and local agencies reported marijuana as the greatest drug threat.
9.3 percent of state and local agencies reported pharmaceuticals as the greatest drug threat.

Return to Map 2.


End of page.